Medscape www.medscape.com

References for:
Quality-of-Life Measurements in Juvenile Rheumatoid Arthritis Patients Treated With Etanercept

[Clin Drug Invest 23(8):511-518, 2003. © 2003 Adis Data Information BV]

  1. Ilowite NT. Current treatment of juvenile rheumatoid arthritis. Pediatrics 2002; 109 (1): 109-15
  2. Perez MD, Abrams SA, Loddeke L, et al. Effects of rheumatic disease and corticosteroid treatment on calcium metabolism and bone density in children assessed one year after diagnosis, using stable isotopes and dual energy x-ray absorptiometry. J Rheumatol 2000; 27 Suppl. 58: 38-43
  3. Haverson PB. Extaarticular manifestations of rheumatoid arthritis. Orthop Nurs 1995; 14 (4): 47-50
  4. Lamblin C, Bergoin C, Saelens T, et al. Interstitial lung diseases in collagen vascular diseases. Eur Respir J 2001; 32 Suppl.: 69s-80s
  5. Schwartz D, Averbuch M, Pines A, et al. Disseminated intravascular coagulation with renal and liver damage as the predominant manifestations of recurrent relapses in systemic juvenile rheumatoid arthritis. Ann Rheum Dis 1992; 51 (3): 347-9
  6. Flato B, Aasland A, Vinje O, et al. Outcome and predictive factors in juvenile rheumatoid arthritis and juvenile spondyloarthropathy. J Rheumatol 1998; 25 (2): 366-75
  7. Petty RE. Prognosis in children with rheumatic diseases: justification for consideration of new therapies. Rheumatology (Oxford) 1999; 38 (8): 739-42
  8. Maini R, Taylor P. Anti-cytokine therapy for rheumatoid arthritis. Annu Rev Med 2000; 51: 207-29
  9. De Benedetti F, Ravelli A, Martini A. Cytokines in juvenile rheumatoid arthritis. Curr Opin Rheumatol 1997; 9: 428-33
  10. Woo P. Cytokines in juvenile chronic arthritis. Baillieres Clin Rheumatol 1998; 12 (2): 219-28
  11. Feldmann M, Brennan F, Maini R. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996; 14: 397-440
  12. Fox DA. Cytokine blockade as a new strategy to treat rheumatoid arthritis: inhibition of tumor necrosis factor. Arch Intern Med 2000; 160 (4): 437-44
  13. Burger D, Dayer JM. Cytokines, acute-phase proteins, and hormones: IL-1 and TNF-alpha production in contact-mediated activation of monocytes by T lymphocytes. Ann N Y Acad Sci 2002; 966: 464-73
  14. Kaneko M, Tomita T, Nakase T, et al. Expression of proteinases and inflammatory cytokines in subchondral bone regions in the destructive joint of rheumatoid arthritis. Rheumatology (Oxford) 2001; 40 (3): 247-55
  15. Lovell D, Giannini E, Reiff A, et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med 2000; 342 (11): 763-9
  16. Woo P. The cytokine network in juvenile chronic arthritis. Ann Med 1997; 29 (2): 145-7
  17. Moreland L, Schiff M, Baumgartner S, et al. Etanercept therapy in rheumatoid arthritis: a randomized, controlled trial. Ann Intern Med 1999; 130 (6): 478-86
  18. Mathias S, Colwell H, Miller D, et al. Health-related quality of life and functional status of patients with rheumatoid arthritis randomly assigned to receive etanercept or placebo. Clin Ther 2000; 22 (1): 128-39
  19. Moreland L, Baumgartner S, Schiff M, et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 1997; 337 (3): 141-7
  20. Kietz DA, Pepmueller PH, Moore TL. Therapeutic use of etanercept in polyarticular course juvenile idiopathic arthritis over a two year period. Ann Rheum Dis 2002; 61 (2): 171-3
  21. Takei S, Groh D, Bernstein B, et al. Safety and efficacy of high dose etanercept in treatment of juvenile rheumatoid arthritis. J Rheumatol 2001; 28 (7): 1677-80
  22. Singh G, Athreya B, Fries J, et al. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum 1994; 37 (12): 1761-9
  23. Duffy CM, Tucker L, Burgos-Vargas R. Update on functional assessment tools. J Rheumatol 2000; 27 Suppl. 58: 11-4
  24. Murphy F, Enzenauer R, Battafarano D, et al. Etanercept associated injection-site reactions. Arch Dermatol 2000; 136 (4): 556-7
  25. Korth-Bradley JM, Rubin A, Hanna R, et al. The pharmacokinetics of etanercept in healthy volunteers. Ann Pharmacother 2000; 34 (2): 161-4